BLOGBLOG

鋭準小編

Breast Cancer Remains Top Among Women for 19 Consecutive Years; Progress in Colorectal Cancer Prevention

Key Takeaways:

  • Breast cancer remains the most common cancer among women in Taiwan.

  • Early detection is crucial for improving survival rates for both breast and colorectal cancer.

  • Regular screening, including mammograms and colonoscopies, is recommended.

  • MarkerX’s MCED service offers a comprehensive approach to cancer prevention.

  • Government-sponsored screening programs play a vital role in early detection.

By prioritizing early prevention, regular health check-ups, and innovative screening technologies like MarkerX’s MCED, we can significantly reduce the burden of cancer and improve the health and well-being of individuals.

The latest cancer registry report released by Taiwan’s Health Promotion Administration for 2021 reveals new trends in cancer prevalence. Breast cancer has maintained its position as the most common cancer among women for 19 consecutive years, with a significant number of cases. In 2022, over 160,000 women sought medical treatment for breast cancer. However, due to the COVID-19 pandemic, the number of women undergoing breast cancer screening in 2021 decreased, with the most significant decline observed among women aged 65-69.

Early Detection is Key to Curing Breast Cancer

 The importance of self-love and early breast cancer screening. For women to promote breast cancer screening among their friends and family.

 

Early detection can significantly improve the five-year survival rate for breast cancer, reaching over 90%. Currently, the government subsidizes biennial mammograms for women aged 45-69 and those aged 40-44 with a family history of breast cancer. However, approximately 15% of breast cancers cannot be detected through mammography. Breast magnetic resonance imaging (MRI), with an accuracy rate exceeding 90%, can help detect early-stage breast cancer.

While MRI is not covered by insurance and can be costly, it offers nearly a 100% cure rate for stage 0 breast cancer. The five-year survival rate for stage 0 to stage I is over 90%. In contrast, the five-year survival rate drops to less than 20% for stage IV breast cancer.

 

Colorectal Cancer Prevention Shows Promise

While breast cancer remains a significant concern, there is positive news regarding colorectal cancer. Thanks to widespread screening programs, the incidence of colorectal cancer in Taiwan has been declining. Early detection through regular screening, such as fecal occult blood tests and colonoscopies, has played a crucial role in improving survival rates.

The Importance of Early Detection and Prevention

Early detection and prevention are essential for improving cancer outcomes. Regular health check-ups and screening programs can help identify cancer at its earliest stages, when treatment is most effective. For both breast and colorectal cancer, the five-year survival rate for early-stage disease is significantly higher compared to advanced stages.

MarkerX: A New Option for Comprehensive Cancer Screening

While government-sponsored screening programs offer valuable benefits, MarkerX’s AI-powered multi-cancer early detection (MCED) service provides a more comprehensive approach to cancer prevention. This innovative service allows individuals to screen for multiple cancer types with a simple blood test, enabling early detection and intervention.

參考資料